(Q43715261)

26 November 2017

title

The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s). (English)

1 reference

26 November 2017

S A Green

1

1 reference

26 November 2017

D A Rathz

series ordinal

2

1 reference

26 November 2017

A J Schuster

series ordinal

3

1 reference

26 November 2017

S B Liggett

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

European Journal of Pharmacology

26 November 2017

published in

1 reference

26 November 2017

volume

421

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

141-147

1 reference

Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Probing the salmeterol binding site on the beta 2-adrenergic receptor using a novel photoaffinity ligand, [(125)I]iodoazidosalmeterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Regular inhaled beta-agonist treatment in bronchial asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Measurement of protein using bicinchoninic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

The use of beta-agonists and the risk of death and near death from asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901049-4

10.1016/S0014-2999(01)01049-4

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference